These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6335331)

  • 1. [Controlling renal osteopathy with keto acids].
    Schmicker R; Fröhling PT; Hohmann WD; Kokot F; Lindenau K; Vetter K
    Z Urol Nephrol; 1984 Nov; 77(11):661-70. PubMed ID: 6335331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of keto acid (KA) treatment on renal osteodystrophy.
    Lindenau K; Kokot F; Vetter K; Schmicker R; Fröhling PT
    Infusionsther Klin Ernahr; 1987 Oct; 14 Suppl 5():40-2. PubMed ID: 3501767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of keto acids in the prophylaxis and treatment of renal osteopathy.
    Fröhling PT; Schmicker R; Lindenau K; Vetter K; Kokot F
    Contrib Nephrol; 1988; 65():123-9. PubMed ID: 3168459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of renal osteodystrophy in advanced renal failure during predialysis time.
    Fröhling PT; Kokot F; Vetter K; Hohmann WD; Werner G; Grossmann I; Schmicker R; Lindenau K
    Contrib Nephrol; 1984; 37():62-5. PubMed ID: 6609046
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
    Teplan V; Schück O; Votruba M; Poledne R; Kazdová L; Skibová J; Malý J
    Wien Klin Wochenschr; 2001 Sep; 113(17-18):661-9. PubMed ID: 11603100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of keto acids on renal osteodystrophy. A prospective controlled study.
    Lindenau K; Abendroth K; Kokot F; Vetter K; Rehse C; Fröhling PT
    Nephron; 1990; 55(2):133-5. PubMed ID: 2132299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative long-term treatment of chronic renal failure with keto acid and amino acid supplementation.
    Schmicker R; Vetter K; Lindenau K; Fröhling PT; Kokot F
    Infusionsther Klin Ernahr; 1987 Oct; 14 Suppl 5():34-8. PubMed ID: 3125108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of keto acids on serum parathyroid hormone levels in patients with chronic renal failure.
    Fröhling PT; Kokot F; Schmicker R; Kaschube I; Lindenau K; Vetter K
    Clin Nephrol; 1983 Oct; 20(4):212-5. PubMed ID: 6641029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
    Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study.
    Zakar G;
    Wien Klin Wochenschr; 2001 Sep; 113(17-18):688-94. PubMed ID: 11603104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients.
    Feiten SF; Draibe SA; Watanabe R; Duenhas MR; Baxmann AC; Nerbass FB; Cuppari L
    Eur J Clin Nutr; 2005 Jan; 59(1):129-36. PubMed ID: 15354199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitamin D treatment and renal osteodystrophy: indications and modalities].
    Fournier A; Morinière P; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
    Nephrologie; 1995; 16(2):165-90. PubMed ID: 7753302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone disease in renal failure. Clinical and histomorphometric studies.
    Nilsson P
    Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hemodialysis, vitamin D metabolites and renal transplantation on the skeletal demineralization associated with renal osteodystrophy: a computerized histomorphometric analysis.
    Main J; Velasco N; Catto GR; Fraser RA; Edward N; Adami S; O'Riordan JL
    Clin Nephrol; 1986 Dec; 26(6):279-87. PubMed ID: 3542321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of keto analogs of essential amino acids on the progress of advanced chronic renal insufficiency: controlled prospective study].
    Chauveau P; Lebkiri B; Ployard F; Ciancioni C; Man NK; Jungers P
    Nephrologie; 1986; 7(4):137-42. PubMed ID: 3796783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5.
    Gravesen E; Hofman-Bang J; Lewin E; Olgaard K
    Scand J Clin Lab Invest; 2013 Mar; 73(2):107-16. PubMed ID: 23281842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.